CATALAYER NEWS
AstraZeneca in China experimental COPD drug deal; upfront payment $200 mln - Reuters
Source: Reuters · 2026-07-07
Full article text is available in the Catalayer news terminal.
MORE FROM REUTERS
Three midweek thoughts - jobs, Fed targets and volatility - Reuters
2026-07-22
From OpenAI to Nvidia, firms channel billions into AI infrastructure as demand booms - Reuters
2026-07-22
Fed rate-hike voices swell before July decision, rates still seen on hold - Reuters
2026-07-17
RELATED ON CATALAYER
Mentioned Tickers
$AZN · AstraZenecaRelated Topics
China Trade & Tech Policy NewsRELATED MARKETS
Prediction Markets